Affimed N.V. AFMD

Quarterly report 2022-Q2
added 08-11-2022

Affimed N.V. DIO Ratio 2011-2026 | AFMD

Annual DIO Ratio Affimed N.V.

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	69.8	83.2	88.5	69.9	92.3	86.9	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
92.3	69.8	81.8

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 21.46	0.47 %	$ 1 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Akebia Therapeutics AKBA	147	$ 1.49	1.35 %	$ 383 M	USA
	Aquestive Therapeutics AQST	120	$ 4.19	-	$ 448 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.98	3.55 %	$ 3.18 B	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.48	0.46 %	$ 394 M	Britain
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	CTI BioPharma Corp. CTIC	38.1	-	-	$ 1.2 B	USA